醒脑静注射液治疗急性重症脑血管病的临床疗效  

Clinical Observation of Xingnaojing Injection in the Treatment of Acute Severe Cerebrovascular Disease

作　　者：王福星[1] WANG Fu-xing(Department of Neurosurgery,Dongli Hospital,Dongli District,Tianjin 300300,China)

机构地区：[1]天津市东丽区东丽医院神经外科,天津300300

出　　处：《医学信息》2020年第18期162-163,共2页Journal of Medical Information

摘　　要：目的观察醒脑静注射液治疗急性重症脑血管病的临床疗效。方法选取2018年7月~2019年7月在我院诊治的134例急性重症脑血管病患者为研究对象,采用随机数字表法分为对照组和观察组,各67例。对照组采用常规治疗,观察组在对照组基础上采用醒脑静注射液治疗,比较两组临床治疗总有效率、神经功能缺损评分、格拉斯哥昏迷(GCS)评分及临床不良反应发生情况。结果观察组临床治疗总有效率为94.02%,高于对照组的80.59%(P<0.05);治疗后两组神经功能缺损评分均低于治疗前,且观察组低于对照组(P<0.05);治疗后两组GCS评分均低于治疗前,且观察组低于对照组(P<0.05);观察组临床不良反应发生率与对照组比较,差异无统计学意义(P>0.05)。结论醒脑静注射液治疗急性重症脑血管病疗效显著,总有效率高,可显著改善患者神经功能缺损,降低GCS评分,且临床不良反应少。Objective To observe the clinical efficacy of Xingnaojing injection in the treatment of acute severe cerebrovascular disease.Methods A total of 134 patients with acute severe cerebrovascular disease diagnosed and treated in our hospital from July 2018 to July 2019 were selected as the research objects.They were divided into control group and observation group by random number table method,with 67 cases in each group.The control group was treated with conventional treatment,and the observation group was treated with Xingnaojing injection on the basis of the control group.The total effective rate of clinical treatment,neurological deficit score,Glasgow coma(GCS)score and the occurrence of clinical adverse reactions were compared between the two groups.Results The total effective rate of clinical treatment in the observation group was 94.02%,which was higher than 80.59%in the control group(P<0.05);the scores of neurological deficits in the two groups after treatment were lower than those before treatment,and the observation group was lower in the control group(P<0.05);after treatment,the GCS scores of the two groups were lower than before treatment,and the observation group was lower than the control group(P<0.05);clinical adverse reactions in the observation group compared with the control group,the incidence rate was not statistically significant(P>0.05).Conclusion Xingnaojing injection had a significant curative effect in the treatment of acute severe cerebrovascular disease.The total effective rate was high.It could significantly improve patients'neurological deficits,reduce GCS scores,and had fewer clinical adverse reactions.

关 键 词：醒脑静注射液 神经功能缺损 脑血管病 

分 类 号：R971[医药卫生—药品]